Clinical potential of aclidinium bromide in chronic obstructive pulmonary disease
Paul W Jones Institute for Infection and Immunity, Faculty of Respiratory Medicine, St George’s, University of London, London, UK Abstract: Three long-acting muscarinic antagonists (LAMAs) are now available in Europe, providing clinicians and patients with a choice of interventions, which is i...
Shranjeno v:
| Glavni avtor: | |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2015-03-01
|
| Serija: | International Journal of COPD |
| Online dostop: | http://www.dovepress.com/clinical-potential-of-aclidinium-bromide-innbspchronicnbspobstructive--peer-reviewed-article-COPD |
| Oznake: |
Brez oznak, prvi označite!
|